0001209191-15-047701.txt : 20150528
0001209191-15-047701.hdr.sgml : 20150528
20150528185916
ACCESSION NUMBER: 0001209191-15-047701
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150526
FILED AS OF DATE: 20150528
DATE AS OF CHANGE: 20150528
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PHARMACYCLICS INC
CENTRAL INDEX KEY: 0000949699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943148201
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: PHARMACYCLICS INC
STREET 2: 995 E ARQUES AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085-4521
BUSINESS PHONE: 408 774 0330
MAIL ADDRESS:
STREET 1: PHARMACYCLICS INC
STREET 2: 995 E ARQUES AVE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085-4521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mehta Minesh
CENTRAL INDEX KEY: 0001446680
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26658
FILM NUMBER: 15896799
MAIL ADDRESS:
STREET 1: 995 EAST ARQUES AVENUE
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-26
0
0000949699
PHARMACYCLICS INC
PCYC
0001446680
Mehta Minesh
C/O PHARMACYCLICS, INC.
995 EAST ARQUES AVENUE
SUNNYVALE
CA
94085
1
0
0
0
Stock Option (Right to Buy)
2.30
2015-05-26
4
D
0
4000
D
2018-09-10
Common Stock
4000
0
D
Stock Option (Right to Buy)
14.26
2015-05-26
4
D
0
7500
D
2021-12-15
Common Stock
7500
0
D
Stock Option (Right to Buy)
28.47
2015-05-26
4
D
0
683
D
2022-04-02
Common Stock
683
0
D
Stock Option (Right to Buy)
59.28
2015-05-26
4
D
0
208
D
2022-07-02
Common Stock
208
0
D
Stock Option (Right to Buy)
65.56
2015-05-26
4
D
0
267
D
2022-10-01
Common Stock
267
0
D
Stock Option (Right to Buy)
49.00
2015-05-26
4
D
0
7500
D
2022-11-09
Common Stock
7500
0
D
Stock Option (Right to Buy)
61.44
2015-05-26
4
D
0
322
D
2023-01-02
Common Stock
322
0
D
Stock Option (Right to Buy)
79.67
2015-05-26
4
D
0
325
D
2023-04-01
Common Stock
325
0
D
Stock Option (Right to Buy)
74.48
2015-05-26
4
D
0
3750
D
2023-05-09
Common Stock
3750
0
D
Stock Option (Right to Buy)
85.39
2015-05-26
4
D
0
304
D
2023-07-01
Common Stock
304
0
D
Stock Option (Right to Buy)
139.89
2015-05-26
4
D
0
184
D
2023-10-01
Common Stock
184
0
D
Stock Option (Right to Buy)
108.44
2015-05-26
4
D
0
238
D
2024-01-02
Common Stock
238
0
D
Stock Option (Right to Buy)
107.42
2015-05-26
4
D
0
157
D
2024-04-01
Common Stock
157
0
D
Stock Option (Right to Buy)
95.08
2015-05-26
4
D
0
3750
D
2024-05-09
Common Stock
3750
0
D
Stock Option (Right to Buy)
89.58
2015-05-26
4
D
0
407
D
2024-07-01
Common Stock
407
0
D
Stock Option (Right to Buy)
115.80
2015-05-26
4
D
0
314
D
2024-10-01
Common Stock
314
0
D
Stock Option (Right to Buy)
124.46
2015-05-26
4
D
0
222
D
2025-01-02
Common Stock
222
0
D
Stock Option (Right to Buy)
257.015
2015-05-26
4
D
0
146
D
2025-04-07
Common Stock
146
0
D
Pursuant to terms of the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie this option was cancelled in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.
/s/ Minesh Mehta
2015-05-27